Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France

The UK's Cancer Drugs Fund: a model for access and reimbursement

The next generation of evidence-based medicine

Summary of key features of HTA agencies.

Personalized Reimbursement Model (PRM) program: A real-world data

Pharmaceutics, Free Full-Text

Federal Register :: Medicare Program; CY 2021 Payment Policies

Federal Register :: Medicare Program; CY 2021 Payment Policies

Frontiers Orphan drugs' clinical uncertainty and prices

Brukinsa: launch sequence of first Chinese cancer drug to roll out

CDx Reimbursement and Funding Challenges and Potential Solutions

Federal Register :: Medicare Program; CY 2021 Payment Policies